Teva’s Partner Antares Swallowed Up By Halozyme In $960m Deal

Teva/Antares Alliance Offers Gx EpiPen; US Forteo Rival Under Development

 
• By Dean Rudge
Handshake
the transaction is expected to close in the first half of 2022 • Source: Shutterstock: LuckyStep

More from Deals

More from Business